No7 Early Defence Day Cream
Avobenzone,octisalate, Octocrylene
Bcm Ltd
Human Otc Drug
NDC 11489-126No7 Early Defence Day Cream also known as Avobenzone,octisalate, Octocrylene is a human otc drug labeled by 'Bcm Ltd'. National Drug Code (NDC) number for No7 Early Defence Day Cream is 11489-126. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in No7 Early Defence Day Cream drug includes Avobenzone - 1.5 g/g Octisalate - 2.5 g/g Octocrylene - 3.75 g/g . The currest status of No7 Early Defence Day Cream drug is Active.
Drug Information:
| Drug NDC: | 11489-126 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | No7 Early Defence Day Cream |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Avobenzone,octisalate, Octocrylene |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Bcm Ltd |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cream |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | AVOBENZONE - 1.5 g/g
OCTISALATE - 2.5 g/g
OCTOCRYLENE - 3.75 g/g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 08 Aug, 2017 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part352 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | BCM Ltd
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | G63QQF2NOX
4X49Y0596W
5A68WGF6WM
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 11489-126-01 | 1 JAR in 1 CARTON (11489-126-01) / 50 g in 1 JAR | 08 Aug, 2017 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Uses uses - helps prevent sunburn
Product Elements:
No7 early defence day cream avobenzone,octisalate, octocrylene avobenzone avobenzone octocrylene octocrylene octisalate octisalate water glycerin aluminum starch octenylsuccinate cetearyl glucoside dimethicone tribehenin ammonium acryloyldimethyltaurate/vp copolymer phenoxyethanol shea butter potassium cetyl phosphate butylene glycol dimethiconol (100000 cst) propylene glycol methylparaben ethylparaben xanthan gum panax ginseng root oil vitamin a palmitate ascorbyl glucoside edetate sodium tert-butyl alcohol dimethylmethoxy chromanol polysorbate 20 medicago sativa leaf potassium hydroxide carbomer 940 morus alba leaf isopropyl myristate sodium benzoate ethylhexylglycerin tocopherol palmitoyl tripeptide-1 palmitoyl tetrapeptide-7
Indications and Usage:
Directions directions apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating children under 6 months of age: ask a doctor sun protection measures. spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad spectrum spf value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m - 2 p.m. wear long-sleeved shirts,pants,hats and sunglasses.
Warnings and Cautions:
Warnings for external use only do not use on damaged or broken skin when using this product keep out of eyes. rinse with water to remove.
Description:
Description no7 early defence skincare system protects and boosts young skin's natural defences to help it look younger for longer. with glow activating serum, for glowing, healthier looking skin in just 1 week. no7 early defence glow activating serum 30ml e 1 us fl.oz no7 early defence day cream sunscreen broad spectrum spf 30 50ml e 1.69 us fl.oz. no7 early defence night cream 50ml e 1.69 us fl.oz.
Description our best defence for young skin when life is fast take control of your skin with no7's early defence skincare, with super light formulations that work to keep young skin looking younger for longer. this daily skincare system includes our no7 early defence day and night creams, which work to slow down the effects that everyday life can have on young skin; as well as our early defence glow activating serum for glowing,healthier looking skin in just 1 week. enriched with our unique double defence technology - a powerful blend of antioxidants - the regime works to help protect your skin from every day environmental stress; while a combination of lipopeptides with vitamin a in our day and night creams- and matrixyl 3000 plus tm in our serum - helps to reduce the appearance of those first fine lines. formulated by no7, leaders in age-defying skincare. serum glowing, healthier looking skin in 1 week. your busy lifestyle, the sun & pollution all put stresses on your skin, dulling its natural radiance and even causing breakouts. our formulation works to boost your skin's natural renewal process, helping clear and refine pores and get your skin glowing again. day by day our unique double defence technology supports your skin's natural defences, reduces your skins's reactivity to stresses, and protects from everyday pollution. powered by matrixyl 3000 plus tm to reduce the appearance of those first fine lines. after just 1 week skin appears more radiant and looks healthier and clearer, withe less visible pores. day cream this super-light and non pore-blocking day cream is formulated with the protective power of sunscreen broad spectrum spf 30 to help give your skin protection from the no 1 cause of visible skin ageing. double defence technology protects skin and boosts natural defences against environmental stress. upon first application skin feels softer and looks more radiant. in just 2 weeks the appearance of pores is visibly reduced. night cream this super-light and non pore-blocking night cream works while you sleep to help skin recover from the day. with double defence technology to give young skin effective night time protection against the damaging effects of free radicals generated from the sun and environmental stress during the day. for best results: after cleansing, smooth no7 early defence glow activating serum on to your face and neck. in the morning, follow with no7 early defence day cream. at night, follow with no7 early defence night cream.
Information for Patients:
The boots company plc nottingham england ng2 3aa dist. in the usa by boots retail usa inc. new york ny 10005 made in the uk www.boots.com/no7
Package Label Principal Display Panel:
Carton image 1 no7earlydefenceskincaresystem2017image1
Carton image 2 no7earlydefenceskincaresystem2017image2